Patients' Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes

被引:8
|
作者
Seo, Jaein [1 ]
Heidenreich, Sebastian [2 ]
Aldalooj, Esraa [2 ]
Poon, Jiat Ling [3 ]
Spaepen, Erik [4 ]
Eby, Elizabeth L. [3 ]
Newson, Rachel S. [5 ]
机构
[1] Patient Ctr Res, Bethesda, MD USA
[2] Patient Ctr Res, London, England
[3] Eli Lilly & Co, Value Evidence & Outcomes, Indianapolis, IN 46285 USA
[4] HaaPACS GmbH, Schriesheim, Germany
[5] Eli Lilly & Co, Med Affairs, Sydney, NSW, Australia
来源
关键词
CONJOINT-ANALYSIS; BLOOD-GLUCOSE; MELLITUS; THERAPY;
D O I
10.1007/s40271-022-00610-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background This study quantified how people with diabetes value the unique features of connected insulin pens and related mobile apps, and the underlying reasons for preferring connected versus non-connected insulin pens. Methods A discrete choice experiment (DCE) was conducted in the USA and UK to elicit preferences of adults (>= 18 years) with type 1 or 2 diabetes for attributes of insulin pens. Attributes included device type, dosing support, glucose monitoring, additional app features, and data sharing. Relative attribute importance (RAI) scores were calculated to capture the relative importance of an attribute. Predicted choice probabilities were obtained to compare different profiles for connected and non-connected insulin pens. Results The DCE was completed by 540 participants (58.9% male; 90.7% Caucasian; mean age, 58.3 years; 69.4% type 2 diabetes). Participants most valued the possibility of using a connected insulin pen with dosing support and automated dose logging (RAI = 39.9%), followed by automatic transfer of glucose levels (RAI = 29.0%), additional features of tracking diet and physical activity (RAI = 14.6%), data sharing (RAI = 13.6%), and device type (RAI = 2.9%). All profiles of connected insulin pens were preferred over a non-connected pen (p < 0.001), and pen profiles with advanced features were preferred over those without (p < 0.001). Preferences differed by age but not diabetes type, country of residence, or insulin regimen. Conclusion People with diabetes in the USA and UK prefer connected over non-connected insulin pens due largely to the availability of automated logging of dose and glucose levels.
引用
收藏
页码:127 / 138
页数:12
相关论文
共 50 条
  • [1] Patients’ Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Patients with Type 1 and Type 2 Diabetes
    Jaein Seo
    Sebastian Heidenreich
    Esraa Aldalooj
    Jiat Ling Poon
    Erik Spaepen
    Elizabeth L. Eby
    Rachel S. Newson
    The Patient - Patient-Centered Outcomes Research, 2023, 16 : 127 - 138
  • [2] PATIENTS' PREFERENCES FOR CONNECTED INSULIN PENS: A DISCRETE CHOICE EXPERIMENT AMONG DIABETES PATIENTS IN THE UK AND US
    Heidenreich, S.
    Seo, J.
    Aldalooj, E.
    Poon, J. L.
    Spaepen, E.
    Eby, E.
    Newson, R.
    VALUE IN HEALTH, 2022, 25 (01) : S233 - S233
  • [3] PATIENTS' PREFERENCES IN ORAL DIABETES TREATMENT: A DISCRETE CHOICE EXPERIMENT IN TYPE2 DIABETES MELLITUS
    Muehlbacher, A. C.
    Bethge, S.
    VALUE IN HEALTH, 2014, 17 (07) : A355 - A355
  • [4] PATIENTS' PREFERENCES FOR ANTIHYPERGLYCEMIC MEDICATIONS FOR TYPE 2 DIABETES: A SYSTEMATIC REVIEW OF DISCRETE CHOICE EXPERIMENT
    Banjara, B.
    Emory, L. A.
    Poudel, N.
    Qian, J.
    Ngorsuraches, S.
    VALUE IN HEALTH, 2021, 24 : S86 - S86
  • [5] Type 2 diabetes patients' preferences and willingness to pay for lifestyle programs: a discrete choice experiment
    Veldwijk, Jorien
    Lambooij, Mattijs S.
    van Gils, Paul F.
    Struijs, Jeroen N.
    Smit, Henriette A.
    de Wit, G. Ardine
    BMC PUBLIC HEALTH, 2013, 13
  • [6] Type 2 diabetes patients’ preferences and willingness to pay for lifestyle programs: a discrete choice experiment
    Jorien Veldwijk
    Mattijs S Lambooij
    Paul F van Gils
    Jeroen N Struijs
    Henriëtte A Smit
    G Ardine de Wit
    BMC Public Health, 13
  • [7] Preferences of people with Type 2 diabetes for diabetes care: a discrete choice experiment
    Hertroijs, D. F. L.
    Elissen, A. M. J.
    Brouwers, M. C. G. J.
    Hiligsmann, M.
    Schaper, N. C.
    Ruwaard, D.
    DIABETIC MEDICINE, 2020, 37 (11) : 1807 - 1815
  • [8] Preferences for Patients with Type 2 Diabetes Mellitus for Medications in Shandong Province, China: A Discrete Choice Experiment
    Lv, Yuyu
    Ren, Ru
    Tang, Chengxiang
    Song, Kuimeng
    Li, Shunping
    Wang, Haipeng
    PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 2335 - 2344
  • [9] Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment
    Morillas, Arlos
    Feliciano, Rosa
    Fernandez Catalina, Pablo
    Ponte, Carla
    Botella, Marta
    Rodrigues, Joao
    Esmatjes, Enric
    Lafita, Javier
    Lizan, Luis
    Llorente, Ignacio
    Morales, Cristobal
    Navarro-Perez, Jorge
    Orozco-Beltran, Domingo
    Paz, Silvia
    Ramirez de Arellano, Antonio
    Cardoso, Cristina
    Tribaldos Causadias, Maribel
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 1443 - 1458
  • [10] Patient preferences for diabetes management among people with type 2 diabetes in Denmark - a discrete choice experiment
    Bogelund, Mette
    Vilsboll, Tina
    Faber, Jens
    Henriksen, Jan Erik
    Gjesing, Rasmus Prior
    Lammert, Morten
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (11) : 2175 - 2183